Amanda McQuade and Nathaniel Robichaud discuss how integrated proteomic and transcriptomic profiling can reveal cellular responses to genetic perturbations that are not captured through RNA analysis ...

Zongertinib in HER2-altered breast cancer: Preclinical activity and preliminary results from a phase Ia dose-escalation study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Genetic configurations and liver niche drive tumor-intrinsic state plasticity in metastatic MSS-CRC. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium. This ...